雄激素受体-话题@MedSci

#雄激素受体#

81篇内容 | 3112人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1350553, encodeId=798d13505535d, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Oncogene：去势抵抗性前列腺癌中环状RNAs能够增加雄激素受体多样性, objectType=article, longId=178184, objectId=9dcd1e81844b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dcd1e81844b, replyNumber=0, likeNumber=130, createdTime=2019-08-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dcd1e81844b, moduleTitle=Oncogene：去势抵抗性前列腺癌中环状RNAs能够增加雄激素受体多样性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dcd1e81844b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350552, encodeId=f107135055285, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Oncogene：肿瘤抑制因子Tp53的缺失能够增强雄激素受体接到的致瘤转化和肿瘤发展, objectType=article, longId=178144, objectId=ea011e814495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea011e814495, replyNumber=0, likeNumber=69, createdTime=2019-08-25, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea011e814495, moduleTitle=Oncogene：肿瘤抑制因子Tp53的缺失能够增强雄激素受体接到的致瘤转化和肿瘤发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea011e814495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350551, encodeId=e5f7135055136, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Oncogene：雄激素受体调控的microRNAs在治疗抗性和治疗靶标中的研究, objectType=article, longId=166390, objectId=b04d166390da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b04d166390da, replyNumber=0, likeNumber=87, createdTime=2019-05-19, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b04d166390da, moduleTitle=Oncogene：雄激素受体调控的microRNAs在治疗抗性和治疗靶标中的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b04d166390da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350550, encodeId=f98e135055013, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Bayer/Orion的非甾体雄激素受体拮抗剂darolutamide治疗前列腺癌获得FDA优先审查, objectType=article, longId=165296, objectId=373b1652964b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=373b1652964b, replyNumber=0, likeNumber=78, createdTime=2019-05-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=373b1652964b, moduleTitle=Bayer/Orion的非甾体雄激素受体拮抗剂darolutamide治疗前列腺癌获得FDA优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=373b1652964b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350549, encodeId=9a0a135054995, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Sci Rep：雄激素受体基因变异在循环无细胞DNA中作为生物标记在去势抵抗性前列腺癌中的应用研究, objectType=article, longId=162867, objectId=d16016286e8c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d16016286e8c, replyNumber=0, likeNumber=107, createdTime=2019-03-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d16016286e8c, moduleTitle=Sci Rep：雄激素受体基因变异在循环无细胞DNA中作为生物标记在去势抵抗性前列腺癌中的应用研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d16016286e8c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350548, encodeId=1ee21350548f2, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=欧盟委员会批准前列腺癌新药Erleada（apalutamide）：口服雄激素受体抑制剂, objectType=article, longId=159087, objectId=b24b15908e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b24b15908e2c, replyNumber=0, likeNumber=100, createdTime=2019-01-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b24b15908e2c, moduleTitle=欧盟委员会批准前列腺癌新药Erleada（apalutamide）：口服雄激素受体抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b24b15908e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350547, encodeId=0bc7135054ea7, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Int J Cancer：多梳家族蛋白EZH2和EED在晚期前列腺癌中能够直接调控雄激素受体, objectType=article, longId=158502, objectId=f2ca158502a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2ca158502a0, replyNumber=0, likeNumber=75, createdTime=2019-01-22, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2ca158502a0, moduleTitle=Int J Cancer：多梳家族蛋白EZH2和EED在晚期前列腺癌中能够直接调控雄激素受体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2ca158502a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350546, encodeId=bb071350546be, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=PNAS：在去势难治性前列腺癌中，以雄激素受体信号为靶标的脂肪生成从头抑制研究, objectType=article, longId=157067, objectId=a8d415e0673c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d415e0673c, replyNumber=0, likeNumber=81, createdTime=2019-01-01, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d415e0673c, moduleTitle=PNAS：在去势难治性前列腺癌中，以雄激素受体信号为靶标的脂肪生成从头抑制研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d415e0673c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350545, encodeId=b724135054589, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Nature Metabolism：雄激素受体驱使的前列腺癌中，线粒体丙酮酸盐输入是代谢的一个弱点, objectType=article, longId=155224, objectId=2bc015522447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bc015522447, replyNumber=0, likeNumber=115, createdTime=2018-12-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bc015522447, moduleTitle=Nature Metabolism：雄激素受体驱使的前列腺癌中，线粒体丙酮酸盐输入是代谢的一个弱点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bc015522447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350544, encodeId=215a135054429, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Nat commun：在晚期前列腺癌中，STUB1/HSP70复合物能够控制对雄激素受体靶向治疗的敏感性, objectType=article, longId=154266, objectId=d915154266bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d915154266bd, replyNumber=0, likeNumber=101, createdTime=2018-11-25, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d915154266bd, moduleTitle=Nat commun：在晚期前列腺癌中，STUB1/HSP70复合物能够控制对雄激素受体靶向治疗的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d915154266bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350543, encodeId=7e6513505436d, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Prostate Cancer P D：雄激素受体在ETS融合阴性前列腺癌中不同的转录特性研究, objectType=article, longId=152894, objectId=a0d91528947c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0d91528947c, replyNumber=0, likeNumber=68, createdTime=2018-11-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0d91528947c, moduleTitle=Prostate Cancer P D：雄激素受体在ETS融合阴性前列腺癌中不同的转录特性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0d91528947c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350542, encodeId=0f24135054272, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Sci Rep：晚期前列腺癌血浆中雄激素受体和血清嗜铬粒蛋白A研究, objectType=article, longId=152234, objectId=adb315223451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adb315223451, replyNumber=0, likeNumber=66, createdTime=2018-10-31, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adb315223451, moduleTitle=Sci Rep：晚期前列腺癌血浆中雄激素受体和血清嗜铬粒蛋白A研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adb315223451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350541, encodeId=e710135054103, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Oncogene：PDZ结合激酶和雄激素受体相互反馈能够驱使前列腺癌发生, objectType=article, longId=150587, objectId=eb0815058eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb0815058eea, replyNumber=0, likeNumber=75, createdTime=2018-10-10, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb0815058eea, moduleTitle=Oncogene：PDZ结合激酶和雄激素受体相互反馈能够驱使前列腺癌发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb0815058eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350540, encodeId=ac791350540da, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Oncogene：肌醇聚磷酸酯4-磷酸酶II型调控雄激素受体的活性, objectType=article, longId=150532, objectId=926a1505322b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=926a1505322b, replyNumber=0, likeNumber=68, createdTime=2018-10-09, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=926a1505322b, moduleTitle=Oncogene：肌醇聚磷酸酯4-磷酸酶II型调控雄激素受体的活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=926a1505322b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350539, encodeId=692e135053962, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Communications Biology：嵌合体ARCC-4靶向蛋白酶水解作用引起的雄激素受体降解要比恩杂鲁胺效果更好, objectType=article, longId=146268, objectId=c61a146268e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61a146268e0, replyNumber=0, likeNumber=76, createdTime=2018-08-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61a146268e0, moduleTitle=Communications Biology：嵌合体ARCC-4靶向蛋白酶水解作用引起的雄激素受体降解要比恩杂鲁胺效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c61a146268e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350538, encodeId=a3e11350538d7, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Brit J Cancer：雄激素受体剪接变异AR-V3, AR-V7和AR-V9在去势难治性前列腺癌转移中是持续共表达的, objectType=article, longId=144947, objectId=441414494efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=441414494efb, replyNumber=0, likeNumber=71, createdTime=2018-07-24, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=441414494efb, moduleTitle=Brit J Cancer：雄激素受体剪接变异AR-V3, AR-V7和AR-V9在去势难治性前列腺癌转移中是持续共表达的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=441414494efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350537, encodeId=bfbe135053e1d, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=PLOS ONE：雄激素受体阳性的三阴乳腺癌：临床病理，预后和预测特征, objectType=article, longId=140463, objectId=744b14046356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744b14046356, replyNumber=0, likeNumber=43, createdTime=2018-06-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744b14046356, moduleTitle=PLOS ONE：雄激素受体阳性的三阴乳腺癌：临床病理，预后和预测特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744b14046356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350536, encodeId=e13813505365d, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Nat Genet：对雄激素受体调控的lncRNA分析鉴定了ARLNC1在前列腺恶化中具有作用, objectType=article, longId=140428, objectId=4276140428c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4276140428c4, replyNumber=0, likeNumber=90, createdTime=2018-06-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4276140428c4, moduleTitle=Nat Genet：对雄激素受体调控的lncRNA分析鉴定了ARLNC1在前列腺恶化中具有作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4276140428c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350535, encodeId=089b135053532, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=CLIN CANCER RES：乳腺癌雄激素受体阳性程度对预测疾病预后至关重要, objectType=article, longId=139784, objectId=4c81139e84ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c81139e84ab, replyNumber=0, likeNumber=89, createdTime=2018-06-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c81139e84ab, moduleTitle=CLIN CANCER RES：乳腺癌雄激素受体阳性程度对预测疾病预后至关重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c81139e84ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1350534, encodeId=dcaa135053488, content=<a href='/topic/show?id=a7689869104' target=_blank style='color:#2F92EE;'>#雄激素受体#</a>, objectTitle=Nat Commun：前馈α粒子放射治疗能够根治雄激素受体依赖的前列腺癌, objectType=article, longId=136900, objectId=a9b513690009, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9b513690009, replyNumber=0, likeNumber=74, createdTime=2018-05-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9b513690009, moduleTitle=Nat Commun：前馈α粒子放射治疗能够根治雄激素受体依赖的前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9b513690009)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

雄激素受体

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Oncogene：去势抵抗性前列腺癌中环状RNAs能够增加雄激素受体多样性

2019-08-27

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Oncogene：肿瘤抑制因子Tp53的缺失能够增强雄激素受体接到的致瘤转化和肿瘤发展

2019-08-25

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Oncogene：雄激素受体调控的microRNAs在治疗抗性和治疗靶标中的研究

2019-05-19

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Bayer/Orion的非甾体雄激素受体拮抗剂darolutamide治疗前列腺癌获得FDA优先审查

2019-05-03

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Sci Rep：雄激素受体基因变异在循环无细胞DNA中作为生物标记在去势抵抗性前列腺癌中的应用研究

2019-03-26

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

欧盟委员会批准前列腺癌新药Erleada（apalutamide）：口服雄激素受体抑制剂

2019-01-29

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Int J Cancer：多梳家族蛋白EZH2和EED在晚期前列腺癌中能够直接调控雄激素受体

2019-01-22

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

PNAS：在去势难治性前列腺癌中，以雄激素受体信号为靶标的脂肪生成从头抑制研究

2019-01-01

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Nature Metabolism：雄激素受体驱使的前列腺癌中，线粒体丙酮酸盐输入是代谢的一个弱点

2018-12-08

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Nat commun：在晚期前列腺癌中，STUB1/HSP70复合物能够控制对雄激素受体靶向治疗的敏感性

2018-11-25

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Prostate Cancer P D：雄激素受体在ETS融合阴性前列腺癌中不同的转录特性研究

2018-11-08

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Sci Rep：晚期前列腺癌血浆中雄激素受体和血清嗜铬粒蛋白A研究

2018-10-31

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Oncogene：PDZ结合激酶和雄激素受体相互反馈能够驱使前列腺癌发生

2018-10-10

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Oncogene：肌醇聚磷酸酯4-磷酸酶II型调控雄激素受体的活性

2018-10-09

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Communications Biology：嵌合体ARCC-4靶向蛋白酶水解作用引起的雄激素受体降解要比恩杂鲁胺效果更好

2018-08-11

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Brit J Cancer：雄激素受体剪接变异AR-V3, AR-V7和AR-V9在去势难治性前列腺癌转移中是持续共表达的

2018-07-24

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

PLOS ONE：雄激素受体阳性的三阴乳腺癌：临床病理，预后和预测特征

2018-06-11

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Nat Genet：对雄激素受体调控的lncRNA分析鉴定了ARLNC1在前列腺恶化中具有作用

2018-06-11

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

CLIN CANCER RES：乳腺癌雄激素受体阳性程度对预测疾病预后至关重要

2018-06-03

zhaojie88 (审核中...)

前往app查看评论内容

#雄激素受体#

Nat Commun：前馈α粒子放射治疗能够根治雄激素受体依赖的前列腺癌

2018-05-02

科室
- - 订阅+
  - 更多科室
工具
服务